Murphy SM, Palmer M, Poole MF, Padegimas L, Hunady K, Danzig J, Gill S, Gill R, Ting A, Sherf B, Brunden K and Stricker-Krongrad A. Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel. J. Pharmacol. Toxicol. Methods.2006;54:42-55.
Huck BR, Llamas L, Robarge MJ, Dent TC, Song J, Hodnick WF, Crumrine C, Stricker-Krongrad A, Harrington J, Brunden KR, and Bennani YL. The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists. Bioorganic Med. Chem. Letters. 2006;16:2891-2894.
Huck BR, Llamas L, Robarge MJ, Dent TC, Song J, Hodnick WF, Crumrine C, Stricker-Krongrad A, Harrington J, Brunden KR and Bennani YL. The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist. Bioorganic Med. Chem. Letters. 2006;16:4130-4134.
Brunden KR, Sherf BA and Harrington JJ. The Application of RAGE and GECKO in Cell-based Target Discovery Screens. Pharmacogenomics. 2005;6:383-392.
Song J, Doucette C, Hanniford D, Hunady K, Wang N, Sherf B, Harrington JJ, Brunden KR and Stricker-Krongrad A. Generation of Cell Lines for Drug Discovery Through Random Amplification of Gene Expression (RAGE): Application to the Human Histamine H3 Receptor. Assay and Drug Development Technol. 2005;3:309-318.
Anderson JT, Ting AE, Boozer S, Brunden KR, Danzig J, Dent T, Harrington JJ, Murphy SM, Perry R, Raber A, Rundlett SE, Wang J, Wang N, and Bennani YL. The discovery of S-phase arresting agents derived from noscapine. J. Med. Chem. 2005; 48:2756-2758.
Robarge MJ, Bom DC, Tumey LN, Varga N, Gleason E, Silver D, Song J, Murphy SM, Ekema G, Doucette C, Hanniford D, Palmer M, Pawlowski G, Danzig J, Loftus M, Hunady K, Sherf BA, Mays RW, Stricker-Krongrad A, Brunden KR, Harrington JJ and Bennani YL. Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists. Bioorganic Med. Chem. Letters. 2005; 15:1749-1753.
Tumey LN, Bom D, Huck B, Gleason E, Wang J, Silver D, Brunden KR, Boozer S, Rundlett S, Sherf B, Harrington J, Murphy S, Dent T, Leventhal C, Bailey A, and. Bennani, YL. The identification and optimization of a N-hydroxy urea series of Flap Endonuclease 1 inhibitors. Bioorganic & Med. Chem. Letters. 2004; 15:277-281.
Tumey LN, Huck B, Gleason E, Wang J, Silver D, Brunden KR, Boozer S, Rundlett, S, Sherf, B, Murphy S, Harrington J, Dent T, Leventhal C, Bailey A, and Bennani, YL. The identification and optimization of 2,4-diketobutyric acids as Flap Endonuclease 1 inhibitors. Bioorganic & Med. Chem. Letters. 2004; 14:4915-4918.
Sherf B, Harrington J, Stark G, et al. Identification of a human NF-κB-activating protein TAB3. Proceedings of the National Academy of Sciences. 2004; 101.7:2028-33.
Grimes BR, Rhoades AA, Willard HF. Alpha-satellite DNA and vector composition influence rates of human artificial chromosome formation. Mol Ther. 2002 Jun;5(6):798-805.
Harrington J, Brunden KR. Drug screening in the genomics era. Current Drug Discovery. 2002; Jan:17-20.
Mays R, Van't Hof W, Deans R, et al. Development of adult pluripotent stem cell therapies for ischemic injury and disease. Expert Opin. Biol. Ther. 2007; 7(2):173-184.
Verfaillie CM, Blazar B, Weismann IL, et al. Hematopoetic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoetic stem cells. Journal of Experimental Medicine. 2007
Van't Hof W, Mal N, Raber A, et al. Multipotent adult progenitor cells. Contemporary Cardiology: Stem Cells and Myocardial Regeneration. Penn MS(Ed.) Humana Press, Inc., MA, USA. 2006: 39-50.
Breyer A, Estharubadi N, Oki M, et al. Multipotent Adult Progenitor Cell(MAPC) isolation and culture procedures. Experimental Hematology. 2006.
Yasuhara T, Matsukawa N, Yu G et al. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant. 2006 15(3):231-238.
Verfaillie CM, Miler RF, Chen A, et al. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proceedings of the National Academy of Sciences Early Edition. 2003; 10.1073/1834196100.
Verfaillie CM, Marker PH, Koodie L, et al. Origin of endothelial progenitors in human postnatal bone marrow. Journal of Clinical Investigation. 2002; 109:337-346.
Verfaillie CM, Largaespada DA, Lisberg A, et al. Pluripotent nature of adult marrow derived from mesenchymal stem cells. Nature. 2002; 418:41-9.
Verfaillie CM, Hu WS, Johnson S, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. Journal of Clinical Investigation. 2002; 109:1291-1302.
Verfaillie LM, Reyes M, Jiang Y, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle and brain. Experimantal Hematology. 2002; 30:896-904.
Basu J, Willard HF. Artificial and engineered chromosomes: non-integrating vectors for gene therapy. Trends Mol Med. 2005 May;11(5):251-8.
Basu J, Stromberg G, Compitello G, Willard HF, Van Bokkelen G. Rapid creation of BAC-based human artificial chromosome vectors by transposition with synthetic alpha-satellite arrays. Nucleic Acids Res. 2005 Jan 26;33(2):587-96.
Willard HF. Neocentromeres and human artificial chromosomes: an unnatural act. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5374-6.
Harrington J, Sherf B, Rundlett S, et al. Creation of genome-wide protein expression libraries using random activation of gene expression. Nature Biotechnology. 2001; 19:440-45.
Harrington J, Van Bokkelen G, Mays R, et al. Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nature Genetics. 1997; 15:345-55.
Roth BL. Drugs and valvular heart disease. N Engl J Med. 2007; 356;1: 6 - 9
Schade R, Andersoh F, et al. Dopamine agonists and the risk of cardiac valve regurgitation. N Engl J Med. 2007; 356;1:29 - 38.
Zanettini R, Antonini A, et al. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med. 2007; 356;1:39 - 46
Van der Goot H, Timmerman H. Selective ligands as tools to study histamine receptors. Eur J Med Chem. 2000; 35:5 - 20.
Beltrami AP, Cesselli D, Bergamin N, et al. Culture of multipotent cells from human tissues. Blood; online publication, May 24, 2007.
De Coppi P, Bartsch G Jr, Diddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 2007; 25(1):100-106.
Anjos-Afonso F, Bonnet D. Non-hematopoietic/endothelial SSEA-1 pos cells defines the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood. 2006 (In Press)
Kucia M, Reca R, Campbell FR, et al. A population of very small embryonic-like (VSEL)CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia. 2006: 20(5):857-869.
Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular(HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005; 23(2):220-229.
Yoon YS, Wecker A, Heyd L et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 2005; 115(2):326-338.
D'Ippolito G, Diabira S, Howard GA et al. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 2004; 117(Pt 14):2971-2981.
Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 2004; 200(2):123-135.